Mattiucci, Gian Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.429
EU - Europa 4.321
AS - Asia 1.449
AF - Africa 33
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 10.273
Nazione #
US - Stati Uniti d'America 4.391
DE - Germania 1.777
SE - Svezia 849
CN - Cina 608
SG - Singapore 432
IT - Italia 410
UA - Ucraina 326
IE - Irlanda 220
FR - Francia 218
ID - Indonesia 135
IN - India 133
GB - Regno Unito 128
FI - Finlandia 97
RU - Federazione Russa 81
TR - Turchia 71
BE - Belgio 55
PL - Polonia 52
CA - Canada 34
CZ - Repubblica Ceca 33
CI - Costa d'Avorio 32
IR - Iran 30
NL - Olanda 19
JP - Giappone 17
AU - Australia 11
EU - Europa 9
CH - Svizzera 8
AT - Austria 7
NO - Norvegia 7
BR - Brasile 6
CL - Cile 6
ES - Italia 6
LT - Lituania 6
HK - Hong Kong 5
VN - Vietnam 5
PT - Portogallo 4
RO - Romania 4
KZ - Kazakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BZ - Belize 2
DK - Danimarca 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
RS - Serbia 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
BG - Bulgaria 1
CM - Camerun 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
LV - Lettonia 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 10.273
Città #
Chandler 1.081
Ashburn 380
Singapore 329
Jacksonville 226
Dublin 220
Ann Arbor 216
San Mateo 202
Dearborn 145
Nanjing 137
Jakarta 133
New York 133
Wilmington 131
Woodbridge 117
Boston 106
Nürnberg 92
Milan 88
Beijing 77
Marseille 72
Princeton 69
Munich 68
Bremen 67
Izmir 65
Fairfield 60
Los Angeles 60
Cattolica 59
Brussels 55
Lawrence 55
Moscow 49
Warsaw 46
Nanchang 45
Redwood City 43
Seattle 42
Houston 37
Rome 33
Zhengzhou 33
Abidjan 32
Helsinki 30
Detroit 29
Boardman 28
Redmond 28
Jiaxing 27
Kunming 27
Leawood 27
Shenyang 27
Cambridge 21
Norwalk 21
Augusta 20
Changsha 20
Tianjin 20
Hebei 18
Pune 17
Toronto 15
Ottawa 14
London 12
Shanghai 12
University Park 12
Fremont 11
Hangzhou 11
Mountain View 11
Ardabil 10
Auburn Hills 10
Washington 10
Brno 9
Falls Church 9
Monmouth Junction 9
Andover 8
Chicago 8
Guangzhou 8
Jinan 8
San Diego 8
Amsterdam 7
Berlin 7
Bologna 7
Hefei 7
Kish 7
Ningbo 7
Albuquerque 6
Bari 6
Dresden 6
Frankfurt am Main 6
Lanzhou 6
Phoenixville 6
San Jose 6
São Paulo 6
Tettnang 6
Indiana 5
Jinhua 5
Lancaster 5
Landshut 5
Las Vegas 5
Saint Louis 5
Tokyo 5
Vienna 5
Atlanta 4
Changchun 4
Corato 4
Edinburgh 4
Fuzhou 4
Hong Kong 4
Kocaeli 4
Totale 5.522
Nome #
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 200
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 177
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 172
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 169
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 167
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 162
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 148
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 142
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 138
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 138
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 136
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 136
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 134
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 133
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 131
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 129
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 129
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 129
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 129
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 127
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 127
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 124
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 121
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 120
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 119
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 115
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 111
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 110
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 109
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 109
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 107
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 106
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 104
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 103
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 102
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 102
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 102
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 102
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 100
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 100
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 98
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 97
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 97
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 96
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 95
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 94
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 91
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 89
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 88
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 88
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 87
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 87
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 84
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 84
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 81
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 81
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 78
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 77
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 77
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 77
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 77
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 74
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 74
Can automation in radiotherapy reduce costs? 73
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 73
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 73
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 73
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 72
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 71
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 69
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 68
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 67
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 67
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 67
In reply to Yamazaki et al 65
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 65
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 65
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 64
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 63
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 63
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 61
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 61
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 60
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 59
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 59
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 58
Prostheses irradiation in high risk breast cancer patients: clinical and aesthetic outcomes in retrospective series 58
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 56
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 55
Robotic radiosurgery in pancreatic cancer: A systematic review 53
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 53
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 52
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 51
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 51
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 49
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 49
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study 49
Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas 48
HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies 48
The impact of radiomics in diagnosis and staging of pancreatic cancer 48
Totale 9.326
Categoria #
all - tutte 43.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.015 0 0 0 0 151 145 146 59 157 70 206 81
2020/2021793 42 86 16 87 125 46 64 20 107 52 133 15
2021/20221.261 121 65 16 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.259 45 340 41 161 46 192 55 89 11 38 123 118
2024/2025625 58 87 176 95 209 0 0 0 0 0 0 0
Totale 10.439